alpha-aminopyridine has been researched along with Vascular Injuries in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Gan, X; Li, S; Li, X; Pei, H; Qiu, C; Sun, X; Wang, Q; Yang, D; Yang, Y | 1 |
Badimon, L; Bendjama, K; Casaní, L; Crespo, J; Cubedo, J; Juan-Babot, O; Lawton, M; Padró, T; Vilahur, G | 1 |
Bruemmer, D; Diebold, S; Endorf, EB; Findeisen, HM; Hess, K; Kahles, F; Lehrke, M; Makowska, A; Marx, J; Marx, N; Stöhr, R; Tilstam, PV | 1 |
3 other study(ies) available for alpha-aminopyridine and Vascular Injuries
Article | Year |
---|---|
Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5'-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway.
Topics: Aminopyridines; AMP-Activated Protein Kinases; Animals; Becaplermin; Carotid Artery, Common; Cell Proliferation; Dipeptides; Disease Models, Animal; Drug Evaluation, Preclinical; Hyperplasia; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Protein Phosphatase 2C; Tumor Suppressor Protein p53; Vascular System Injuries | 2019 |
Roflumilast-induced Local Vascular Injury Is Associated with a Coordinated Proteome and Microparticle Change in the Systemic Circulation in Pigs.
Topics: Aminopyridines; Animals; Benzamides; Biomarkers; Blood Proteins; Cell-Derived Microparticles; Cyclopropanes; Female; Interleukin-6; Phosphodiesterase 4 Inhibitors; Proteome; Proteomics; Swine; Vascular System Injuries | 2015 |
PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Topics: Aminopyridines; Animals; Benzamides; Cell Adhesion; Cell Line; Cell Proliferation; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Femoral Artery; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Histones; Humans; Mice; Monocytes; Myocytes, Smooth Muscle; Neointima; Phosphodiesterase 4 Inhibitors; Rats; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vascular System Injuries | 2015 |